Breast ductal secretions: Clinical features, potential uses, and possible applications

Cancer Control

Volumn 14, Issue 4, 2007, Pages 350-359

  Lang, Julie E ^a,b   Kuerer, Henry M ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b UNIVERSITY OF ARIZONA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BREAST CARCINOMA; BREAST DISCHARGE; BREAST DUCT; BREAST PAPILLOMA; BREAST SURGERY; CLINICAL EVALUATION; CLINICAL FEATURE; CYTOLOGY; DIAGNOSTIC PROCEDURE; DISEASE COURSE; ENDOSCOPY; HIGH RISK PATIENT; HUMAN; LACTATION; NIPPLE ASPIRATION; PATHOGENESIS; REVIEW;

EID: 37249045923     PISSN: 10732748     EISSN: 15262359     Source Type: Journal    
DOI: 10.1177/107327480701400405     Document Type: Review

References (76)

1. Dixon JM, Mansel RE. ABC of breast diseases: symptoms assessment and guidelines for referral. BMJ. 1994;309:722-726.
2. Dawes LG, Bowen C, Venta LA, et al. Ductography for nipple discharge: no replacement for ductal excision. Surgery. 1998;124:685-691.
3. Leis HP Jr. Management of nipple discharge. World J Surg. 1989;13:736-742.
4. King TA, Carter KM, Bolton JS, et al. A simple approach to nipple discharge. Am Surg. 2000;66:960-965; discussion 965-966.
5. Murad TM, Contesso G, Mouriesse H. Nipple discharge from the breast. Ann Surg. 1982;195:259-264.
6. Florio MG, Manganaro T, Pollicino A, et al. Surgical approach to nipple discharge: a ten-year experience. J Surg Oncol. 1999;71:235-238.
7. Locker AP, Galea MH, Ellis IO, et al. Microdochectomy for single-duct discharge from the nipple. Br J Surg. 1988;75:700-701.
8. Gulay H, Bora S, Kilicturgay S, et al. Management of nipple discharge. J Am Coll Surg. 1994;178:471-474.
9. Carty NJ, Mudan SS, Ravichandran D, et al. Prospective study of outcome in women presenting with nipple discharge. Ann R Coll Surg Engl. 1994;76:387-389.
10. Ibarra JA. Papillary lesions of the breast. Breast J. 2006;12:237-251.
11. Orel SG, Dougherty CS, Reynolds C, et al. MR imaging in patients with nipple discharge: initial experience. Radiology. 2000;216:248-254.
12. Chaudary MA, Millis RR, Davies GC, et al. The diagnostic value of testing for occult blood. Ann Surg. 1982;196:651-655.
13. Van Zee KJ, Ortega Pérez G, Minnard E, et al. Preoperative galactography increases the diagnostic yield of major duct excision for nipple discharge. Cancer. 1998;82:1874-1880.
14. Wellings SR, Jensen HM, Marcum RG. An atlas of subgross pathology of the human breast with special reference to possible precancerous lesions. J Natl Cancer Inst. 1975;55:231-273.
15. Mokbel K, Escobar PF, Matsunaga T. Mammary ductoscopy: current status and future prospects. Eur J Surg Oncol. 2005;31:3-8.
16. Going JJ, Mohun TJ. Human breast duct anatomy, the "sick lobe" hypothesis and intraductal approaches to breast cancer. Breast Cancer Res Treat. 2006;97:285-291.
17. Jensen HM, Rice JR, Wellings SR. Preneoplastic lesions in the human breast. Science. 1976;191:295-297.
18. King BL, Love SM. The intraductal approach to the breast: raison d'être. Breast Cancer Res. 2006;8:206.
19. Dua RS, Isacke CM, Gui GP. The intraductal approach to breast cancer biomarker discovery. J Clin Oncol. 2006;24:1209-1216.
20. Dietz JR, Crowe JP, Grundfest S, et al. Directed duct excision by using mammary ductoscopy in patients with pathologic nipple discharge. Surgery. 2002;132:582-587; discussion 587-588.
21. Dooley WC. Routine operative breast endoscopy for bloody nipple discharge. Ann Surg Oncol. 2002;9:920-923.
22. Moncrief RM, Nayar R, Diaz LK, et al. A comparison of ductoscopy-guided and conventional surgical excision in women with spontaneous nipple discharge. Ann Surg. 2005;241:575-581.
23. Escobar PF, Crowe JP, Matsunaga T, et al. The clinical applications of mammary ductoscopy. Am J Surg. 2006;191:211-215.
24. Kim JA, Crowe JP, Woletz J, et al. Prospective study of intraoperative mammary ductoscopy in patients undergoing partial mastectomy for breast cancer. Am J Surg. 2004;188:411-414.
25. Dooley WC, Ljung BM, Veronesi U, et al. Ductal lavage for detection of cellular atypia in women at high risk for breast cancer. J Natl Cancer Inst. 2001;93:1624-1632.
26. Wrensch MR, Petrakis NL, Miike R, et al. Breast cancer risk in women with abnormal cytology in nipple aspirates of breast fluid. J Natl Cancer Inst. 2001;93:1791-1798.
27. Zhao Y, Verselis SJ, Klar N, et al. Nipple fluid carcinoembryonic antigen and prostate-specific antigen in cancer-bearing and tumor-free breasts. J Clin Oncol. 2001;19:1462-1467.
28. Evron E, Dooley WC, Umbricht CB, et al. Detection of breast cancer cells in ductal lavage fluid by methylation-specific PCR. Lancet. 2001;357:1335-1336.
29. Sartorius OW, Smith HS, Morris P, et al. Cytologic evaluation of breast fluid in the detection of breast disease. J Natl Cancer Inst. 1977;59:1073-1080.
30. Petrakis NL. Physiologic, biochemical, and cytologic aspects of nipple aspirate fluid. Breast Cancer Res Treat. 1986;8:7-19.
31. Kuerer HM, Thompson PA, Krishnamurthy S, et al. High and differential expression of HER-2/neu extracellular domain in bilateral ductal fluids from women with unilateral invasive breast cancer. Clin Cancer Res. 2003;9:601-605.
32. Slamon DJ, Leyland-Jones B, Shak S, et al. Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2. N Engl J Med. 2001;344:783-792.
33. Liu Y, Wang JL, Chang H, et al. Breast-cancer diagnosis with nipple fluid bFGF. Lancet. 2000;356:567.
34. Kahana L, Bartal AH, Yechieli H, et al. Carcinoembryonic-like substance in breast fluid discharge in benign and malignant breast disease and in milk of lactating women. Isr J Med Sci. 1981;17:1035-1040.
35. Inaji H, Yayoi E, Maeura Y, et al. Carcinoembryonic antigen estimation in nipple discharge as an adjunctive tool in the diagnosis of early breast cancer. Cancer. 1987;60:3008-3013.
36. Mori T, Inaji H, Koyama H, et al. Evaluation of an improved dot-immunobinding assay for carcinoembryonic antigen determination in nipple discharge in early breast cancer: results of a multicenter study. Jpn J Clin Oncol. 1992;22:371-376.
37. Imayama S, Mori M, Ueo H, et al. Presence of elevated carcinoembryonic antigen on absorbent disks applied to nipple area of breast carcinoma patients. Cancer. 1996;78:1229-1234.
38. Foretova L, Garber JE, Sadowsky NL, et al. Carcinoembryonic antigen in breast nipple aspirate fluid. Cancer Epidemiol Biomarkers Prev. 1998;7:195-198.
39. Malatesta M, Mannello F, Bianchi G, et al. Biochemical and ultrastructural features of human milk and nipple aspirate fluids. J Clin Lab Anal. 2000;14:330-335.
40. Chen G, Djuric Z. Detection of 2,6-cyclolycopene-1,5-diol in breast nipple aspirate fluids and plasma: a potential marker of oxidative stress. Cancer Epidemiol Biomarkers Prev. 2002;11:1592-1596.
41. Petrakis NL, Gruenke LD, Craig JC. Cholesterol and cholesterol epoxides in nipple aspirates of human breast fluid. Cancer Res. 1981;41:2563-2565.
42. Miller WR, Humeniuk V, Forrest AP. Factors affecting dehydroepiandrosterone sulphate levels in human breast secretions. Breast Cancer Res Treat. 1981;1:267-272.
43. Gann P, Chatterton R, Vogelsong K, et al. Mitogenic growth factors in breast fluid obtained from healthy women: evaluation of biological and extraneous sources of variability. Cancer Epidemiol Biomarkers Prev. 1997;6:421-428.
44. Ernster VL, Wrensch MR, Petrakis NL, et al. Benign and malignant breast disease: initial study results of serum and breast fluid analyses of endogenous estrogens. J Natl Cancer Inst. 1987;79:949-960.
45. Inaji H, Koyama H, Motomura K, et al. ErbB-2 protein levels in nipple discharge: role in diagnosis of early breast cancer. Tumour Biol. 1993;14:271-278.
46. Black MH, Magklara A, Obiezu C, et al. Expression of a prostate-associated protein, human glandular kallikrein (hK2), in breast tumours and in normal breast secretions. Br J Cancer. 2000;82:361-367.
47. Petrakis NL, Doherty M, Lee R, et al. Immunoglobulin levels in breast fluids of women with breast cancer. Clin Immunol Immunopathol. 1977;7:386-393.
48. Yap PL, Miller WR, Humeniuk V, et al. Milk protein concentrations in the mammary secretions of non-lactating women. J Reprod Immunol. 1981;3:49-58.
49. Kawamoto M. Breast cancer diagnosis by lactate dehydrogenase isozymes in nipple discharge. Cancer. 1994;73:1836-1841.
50. Wynder EL, Hill P, Laakso K, et al. Breast secretion in Finnish women: a metabolic epidemiologic study. Cancer. 1981;47:1444-1450.
51. Rose DP, Berke B, Cohen LA, et al. A comparison of serum and breast duct fluid-immunoassayable prolactin and growth hormone with bioassayable lactogenic hormones in healthy women and patients with cystic breast disease. Cancer. 1987;60:2761-2765.
52. Rose DP, Tilton K, Lahti H, et al. Progesterone levels in breast duct fluid. Eur J Cancer Clin Oncol. 1986;22:111-113.
53. Sauter ER, Babb J, Daly M, et al. Prostate-specific antigen production in the female breast: association with progesterone. Cancer Epidemiol Biomarkers Prev. 1998;7:315-320.
54. Harding C, Osundeko O, Tetlow L, et al. Hormonally-regulated proteins in breast secretions are markers of target organ sensitivity. Br J Cancer. 2000;82:354-360.
55. Hill P, Garbaczewski L, Wynder EL. Testosterone in breast fluid. Lancet. 1983;1:761.
56. Petrakis NL. Nipple aspirate fluid in epidemiologic studies of breast disease. Epidemiol Rev. 1993;15:188-195.
57. Pawlik TM, Fritsche H, Coombes KR, et al. Significant differences in nipple aspirate fluid protein expression between healthy women and those with breast cancer demonstrated by time-of-flight mass spectrometry. Breast Cancer Res Treat. 2005;89:149-157.
58. Pawlik TM, Hawke DH, Liu Y, et al. Proteomic analysis of nipple aspirate fluid from women with early-stage breast cancer using isotope-coded affinity tags and tandem mass spectrometry reveals differential expression of vitamin D binding protein. BMC Cancer. 2006;6:68.
59. Coombes KR, Fritsche HA Jr, Clarke C, et al. Quality control and peak finding for proteomics data collected from nipple aspirate fluid by surface-enhanced laser desorption and ionization. Clin Chem. 2003;49:1615-1623.
60. Li J, Zhang Z, Rosenzweig J, et al. Proteomics and bioinformatics approaches for identification of serum biomarkers to detect breast cancer. Clin Chem. 2002;48:1296-1304.
61. Li J, Zhao J, Yu X, et al. Identification of biomarkers for breast cancer in nipple aspiration and ductal lavage fluid. Clin Cancer Res. 2005;11:8312-8320.
62. Krishnamurthy S, Sneige N, Thompson PA, et al. Nipple aspirate fluid cytology in breast carcinoma. Cancer. 2003;99:97-104.
63. King EB, Barrett D, King MC, et al. Cellular composition of the nipple aspirate specimen of breast fluid. I. The benign cells. Am J Clin Pathol. 1975;64:728-738.
64. King EB, Barrett D, Petrakis NL. Cellular composition of the nipple aspirate specimen of breast fluid. II. Abnormal findings. Am J Clin Pathol. 1975;64:739-748.
65. Zhu W, Qin W, Ehya H, et al. Microsatellite changes in nipple aspirate fluid and breast tissue from women with breast carcinoma or its precursors. Clin Cancer Res. 2003;9:3029-3033.
66. Krassenstein R, Sauter E, Dulaimi E, et al. Detection of breast cancer in nipple aspirate fluid by CpG island hypermethylation. Clin Cancer Res. 2004;10:28-32.
67. Dooley WC, Ljung BM, Veronesi U, et al. Ductal lavage for detection of cellular atypia in women at high risk for breast cancer. J Natl Cancer Inst. 2001;93:1624-1632.
68. Morrow M, Vogel V, Ljung BM, et al. Evaluation and management of the woman with an abnormal ductal lavage. J Am Coll Surg. 2002;194:648-656.
69. Khan SA, Wiley EL, Rodriguez N, et al. Ductal lavage findings in women with known breast cancer undergoing mastectomy. J Natl Cancer Inst. 2004;96:1510-1517.
70. Khan SA, Wolfman JA, Segal L, et al. Ductal lavage findings in women with mammographic microcalcifications undergoing biopsy. Ann Surg Oncol. 2005;12:689-696.
71. King BL, Tsai SC, Gryga ME, et al. Detection of chromosomal instability in paired breast surgery and ductal lavage specimens by interphase fluorescence in situ hybridization. Clin Cancer Res. 2003;9:1509-1516.
72. Fackler MJ, Malone K, Zhang Z, et al. Quantitative multiplex methylation-specific PCR analysis doubles detection of tumor cells in breast ductal fluid. Clin Cancer Res. 2006;12:3306-3310.
73. Cabioglu N, Hunt KK, Singletary SE, et al. Surgical decision making and factors determining a diagnosis of breast carcinoma in women presenting with nipple discharge. J Am Coll Surg. 2003;196:354-364.
74. Groves AM, Carr M, Wadhera V, et al. An audit of cytology in the evaluation of nipple discharge: a retrospective study of 10 years' experience. Breast. 1996;5:96-99.
75. Johnson TL, Kini SR. Cytologic and clinicopathologic features of abnormal nipple secretions: 225 cases. Diagn Cytopathol. 1991;7:17-22.
76. Dinkel HP, Gassel AM, Müller T, et al. Galactography and exfoliative cytology in women with abnormal nipple discharge. Obstet Gynecol. 2001;97:625-629.